ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,590Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 231

$428K Total Retail Price of All Prescriptions

Rank: 44 out of 231

292 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

31% of this provider’s 292 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 292 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 5,991 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
FUROSEMIDE 328 217 1 6
OMEPRAZOLE 249 218 2 5
SIMVASTATIN 246 180 3 2
LISINOPRIL 237 184 4 1
WARFARIN SODIUM 221 124 5 17
MIRTAZAPINE 197 186 6 25
METOPROLOL TARTRATE 167 112 7 12
SERTRALINE HCL 167 105 7 18
TRAZODONE HCL 158 127 9 35
ALBUTEROL SULFATE 157 114 10 66
PRAVASTATIN SODIUM 146 133 11 10
DIVALPROEX SODIUM 139 78 12 53
CITALOPRAM HBR 135 92 13 20
IPRATROPIUM-ALBUTEROL 131 88 14 68
AMLODIPINE BESYLATE 129 84 15 4
LEVOTHYROXINE SODIUM 128 125 16 3
TRAMADOL HCL 126 88 17 16
QUETIAPINE FUMARATE 121 103 18 39
IPRATROPIUM BROMIDE 117 84 19 123
CARVEDILOL 103 72 20 24
RANITIDINE HCL 102 96 21 51
OXYCODONE-ACETAMINOPHEN 98 68 S2 22 52
LANTUS 96 57 23 42
TAMSULOSIN HCL 93 88 24 30
METFORMIN HCL 85 55 25 7
NITROFURANTOIN MONO-MACRO 84 61 26 76
RISPERIDONE 83 21 27 34
OXYCODONE HCL 82 64 S2 28 23
GABAPENTIN 81 44 29 15
LEVETIRACETAM 80 48 30 57
DONEPEZIL HCL 80 80 30 26
FENTANYL 78 20 S2 32 69
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 59 33 77
NOVOLOG 71 31 34 72
CLOPIDOGREL 69 67 35 44
CIPROFLOXACIN HCL 67 58 36 58
POTASSIUM CHLORIDE 65 59 37 33
OXYCONTIN 65 33 S2 37 74
NAMENDA 64 64 39 47
DOXYCYCLINE HYCLATE 61 52 40 98
LANTUS SOLOSTAR 61 38 40 90
HUMALOG 59 19 42 92
AMIODARONE HCL 59 34 42 108
KLOR-CON M20 57 28 44 75
ISOSORBIDE MONONITRATE ER 57 44 44 56
DIOVAN 55 51 46 27
LYRICA 53 24 47 115
GLIPIZIDE 51 45 48 71
METOPROLOL SUCCINATE 50 47 49 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.